SG Americas Securities’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,366
Closed -$101K 3760
2025
Q3
$101K Buy
+3,366
New +$112K ﹤0.01% 3080
2025
Q2
Sell
-5,111
Closed -$156K 3548
2025
Q1
$156K Sell
5,111
-1,829
-26% -$61.6K ﹤0.01% 2717
2024
Q4
$275K Buy
6,940
+1,255
+22% +$48.8K ﹤0.01% 1867
2024
Q3
$220K Buy
+5,685
New +$230K ﹤0.01% 2414
2024
Q2
Sell
-5,138
Closed -$151K 3282
2024
Q1
$151K Buy
5,138
+660
+15% +$21K ﹤0.01% 2202
2023
Q4
$163K Buy
+4,478
New +$147K ﹤0.01% 2350
2023
Q2
Sell
-7,605
Closed -$173K 3102
2023
Q1
$173K Buy
+7,605
New +$196K ﹤0.01% 2533
2022
Q2
Sell
-5,896
Closed -$267K 3598
2022
Q1
$267K Sell
5,896
-7,316
-55% -$320K ﹤0.01% 2256
2021
Q4
$636K Buy
13,212
+117
+0.9% +$5.89K ﹤0.01% 1984
2021
Q3
$728K Buy
+13,095
New +$728K ﹤0.01% 2184
2021
Q2
Sell
-6,363
Closed -$357K 3210
2021
Q1
$357K Sell
6,363
-3,073
-33% -$153K ﹤0.01% 2248
2020
Q4
$411K Buy
+9,436
New +$371K ﹤0.01% 2134
2020
Q3
Sell
-8,628
Closed -$373K 3398
2020
Q2
$373K Sell
8,628
-2,483
-22% -$94K ﹤0.01% 2347
2020
Q1
$370K Buy
11,111
+6,373
+135% +$230K ﹤0.01% 2070
2019
Q4
$196K Buy
+4,738
New +$199K ﹤0.01% 2490
2019
Q3
Sell
-65,852
Closed -$2.84M 3195
2019
Q2
$2.84M Buy
65,852
+60,728
+1,185% +$2.56M 0.02% 809
2019
Q1
$223K Buy
+5,124
New +$261K ﹤0.01% 2490
2018
Q4
Sell
-3,612
Closed -$270K 3309
2018
Q3
$270K Sell
3,612
-764
-17% -$52.6K ﹤0.01% 2417
2018
Q2
$242K Buy
4,376
+1,180
+37% +$54.5K ﹤0.01% 2481
2018
Q1
$122K Buy
+3,196
New +$99K ﹤0.01% 2795
2017
Q4
Sell
-3,729
Closed -$116K 3599
2017
Q3
$116K Buy
+3,729
New +$101K ﹤0.01% 3090

Other funds holding SRDX

SG Americas Securities's SRDX Position: Q4 2025 in Review

SG Americas Securities sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 3,366 shares — an estimated $101K sold.

SG Americas Securities first reported a position in SRDX in Q3 2017 and held it in 21 quarters. The position peaked at $2.84M in Q2 2019. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • SG Americas Securities reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • SG Americas Securities sold 3,366 Surmodics shares in Q4 2025, an estimated $101K.
  • SG Americas Securities first reported a position in Surmodics in Q3 2017 and held it in 21 quarters.
  • SG Americas Securities's Surmodics position peaked at $2.84M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on SG Americas Securities's 13F filing for Q4 2025, filed 9 Jan 2026.